Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions — Stella

Recruiting

Back to Coronary Angioplasty trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

France

Clermont Ferrand Hospital, Clermont-Ferrand, Auvergne

CHU de Clermont-Ferrand, Clermont-Ferrand

Key details

Sponsor

University Hospital, Clermont-Ferrand

Enrollment target

~80 participants

Started

October 2025

Primary completion

September 2028

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov